Tamoxifen modulation of carboplatin cytotoxicity in a human U-138 glioma cell line (Q41007427)

25 September 2017

Tamoxifen modulation of carboplatin cytotoxicity in a human U-138 glioma cell line (English)

1 reference

25 September 2017

1 reference

1 reference

1

Mastronardi L

1 reference

25 September 2017

Farah JO

2

1 reference

PubMed ID

9746294

25 September 2017

Puzzilli F

series ordinal

3

1 reference

PubMed ID

9746294

25 September 2017

Ruggeri A

series ordinal

4

1 reference

25 September 2017

1 June 1998

1 reference

Clinical Neurology and Neurosurgery

25 September 2017

1 reference

25 September 2017

100

1 reference

25 September 2017

2

1 reference

25 September 2017

89-93

1 reference

Chemotherapy for malignant gliomas

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

National survey of patterns of care for brain-tumor patients

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Long-term survival and recurrence-free interval in combined surgical, radio- and chemotherapy of malignant brain gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Survival in glioblastoma: historical perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Enhancement of radiosensitivity by tamoxifen in C6 glioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

A pilot study of cis-diamminedichloroplatinum and radiation therapy in patients with high grade astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

A phase II study of intravenous carboplatin for the treatment of recurrent gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Rapid determination of CSF lymphocyte subsets by labeled microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Role of protein kinase C in glial cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Tamoxifen in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of "failed" patients

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

The biochemistry of P-glycoprotein-mediated multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

Tamoxifen modulation of cisplatin cytotoxicity in human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2898%2900004-3

7 January 2021

10.1016/S0303-8467(98)00004-3

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

9746294